170 related articles for article (PubMed ID: 16085594)
21. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
Sato M; Okumura T; Kaito K; Kiyoshima M; Asato Y; Uchiumi K; Iijima H; Hashimoto I; Kaburagi T; Amemiya R
Ann Nucl Med; 2009 Jan; 23(1):49-57. PubMed ID: 19205838
[TBL] [Abstract][Full Text] [Related]
22. Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT.
Dirisamer A; Schima W; Heinisch M; Weber M; Lehner HP; Haller J; Langsteger W
Eur J Radiol; 2009 Mar; 69(3):536-41. PubMed ID: 18248928
[TBL] [Abstract][Full Text] [Related]
23. Automatic registration of PET and CT studies for clinical use in thoracic and abdominal conformal radiotherapy.
Rizzo G; Castiglioni I; Arienti R; Cattaneo GM; Landoni C; Artioli D; Gilardi MC; Messa C; Reni M; Ceresoli GL; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):267-79. PubMed ID: 16172573
[TBL] [Abstract][Full Text] [Related]
24. F-18 FDG PET/CT in the management of thyroid cancer.
Iagaru A; Kalinyak JE; McDougall IR
Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of pulmonary nodules and lung cancer with one-inch crystal gamma coincidence positron emission tomography/CT versus dedicated positron emission tomography/CT.
Moodie K; Cherk MH; Lau E; Turlakow A; Skinner S; Hicks RJ; Kelly MJ; Kalff V
J Med Imaging Radiat Oncol; 2009 Feb; 53(1):32-9. PubMed ID: 19453526
[TBL] [Abstract][Full Text] [Related]
26. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
D'souza MM; Sharma R; Mondal A; Jaimini A; Tripathi M; Saw SK; Singh D; Mishra A; Tripathi RP
Nucl Med Commun; 2009 Feb; 30(2):117-25. PubMed ID: 19057427
[TBL] [Abstract][Full Text] [Related]
28. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G
Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181
[TBL] [Abstract][Full Text] [Related]
29. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
Beyer T; Bockisch A; Kühl H; Martinez MJ
J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
[TBL] [Abstract][Full Text] [Related]
30. Granulomatous disease: is it a nuisance or an asset during PET/computed tomography evaluation of lung cancers?
Chundru S; Wong CY; Wu D; Balon H; Palka J; Chang CY; Gaskill M; Cheng CY; Huang WS; Fink-Bennett D
Nucl Med Commun; 2008 Jul; 29(7):623-7. PubMed ID: 18528184
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG PET/CT for staging of penile cancer.
Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
[TBL] [Abstract][Full Text] [Related]
32. Screening for cancer with PET and PET/CT: potential and limitations.
Schöder H; Gönen M
J Nucl Med; 2007 Jan; 48 Suppl 1():4S-18S. PubMed ID: 17204716
[TBL] [Abstract][Full Text] [Related]
33. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.
Coleman RE; Delbeke D; Guiberteau MJ; Conti PS; Royal HD; Weinreb JC; Siegel BA; Federle MF; Townsend DW; Berland LL; ; ;
J Nucl Med; 2005 Jul; 46(7):1225-39. PubMed ID: 16000293
[TBL] [Abstract][Full Text] [Related]
34. Frequency and follow-up of incidental findings on trauma computed tomography scans: experience at a level one trauma center.
Munk MD; Peitzman AB; Hostler DP; Wolfson AB
J Emerg Med; 2010 Apr; 38(3):346-50. PubMed ID: 18804935
[TBL] [Abstract][Full Text] [Related]
35. Practical approach to diagnostic CT combined with PET.
Wong TZ; Paulson EK; Nelson RC; Patz EF; Coleman RE
AJR Am J Roentgenol; 2007 Mar; 188(3):622-9. PubMed ID: 17312045
[TBL] [Abstract][Full Text] [Related]
36. Detection of unexpected additional primary malignancies with PET/CT.
Ishimori T; Patel PV; Wahl RL
J Nucl Med; 2005 May; 46(5):752-7. PubMed ID: 15872346
[TBL] [Abstract][Full Text] [Related]
37. Incidental finding of renal masses at unenhanced CT: prevalence and analysis of features for guiding management.
O'Connor SD; Pickhardt PJ; Kim DH; Oliva MR; Silverman SG
AJR Am J Roentgenol; 2011 Jul; 197(1):139-45. PubMed ID: 21701022
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic evaluation of separately acquired PET and CT images by nuclear medicine physicians and radiologists in cancer patients.
Quarles van Ufford HM; Quekel LG; van Waes PF; de Haas PJ; de Klerk JM
Hell J Nucl Med; 2007; 10(2):105-8. PubMed ID: 17684586
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of extraskeletal computed tomography findings on 18F-NaF PET/CT performed for osseous metastatic disease evaluation.
Guo HH; Moradi F; Iagaru A
Nucl Med Commun; 2016 Sep; 37(9):975-82. PubMed ID: 27111100
[TBL] [Abstract][Full Text] [Related]
40. [Quality control in PET/CT systems: experiences and requirements].
Geworski L; Karwarth C; Fitz E; Plotkin M; Knoop B
Z Med Phys; 2010; 20(1):46-50. PubMed ID: 20304719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]